Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial (Q44315403)
Jump to navigation
Jump to search
scientific article published in February 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial |
scientific article published in February 2003 |
Statements
1 reference
Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial (English)
1 reference
Bernard A Zonnenberg
1 reference
Nicholas J Vogelzang
1 reference
Michael A Carducci
1 reference
Robert J Padley
1 reference
Jurgen Breul
1 reference
Danai D Daliani
1 reference
Claude C Schulman
1 reference
Azmi A Nabulsi
1 reference
Rod A Humerickhouse
1 reference
Mark A Weinberg
1 reference
Jennifer L Schmitt
1 reference
Joel B Nelson
1 reference
1 February 2003
1 reference
1 reference
21
1 reference
4
1 reference
679-689
1 reference
Identifiers
1 reference
1 reference